REFERENCES
- US Drug Enforcement Administration. Special Report: Synthetic Cannabinoids and Synthetic Cathinones Reported in NFLIS, 2009–2010. Springfield, VA: US Drug Enforcement Administration, 2011.
- James D, Adams RD, Spears R, Cooper G, Lupton DJ, Thompson JP, Thomas SH; on behalf of the National Poisons Information Service. Clinical characteristics of mephedrone toxicity reported to the UK National Poisons Information Service. Emerg Med J 2011; 28:686–689.
- Spiller HA, Ryan ML, Weston RG, Jansen J. Clinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United States. Clin Toxicol (Phila) 2011; 49:499–505.
- Herbert JX, Tracey JA, Duggan E. Bath salts and plant feeder pills: Synthetic cathinone abuse in Ireland. Clin Toxicol (Phila) 2011; 49:213.
- Thomas SH, James DA, Spears R, Cooper G, Wood K, Dyas J, Adams RD, Lupton DJ, Good AM. Effects of legal control on enquiries to the UK National Poisons Information Service relating to recreational cathinone use. Clin Toxicol (Phila) 2011; 49:214.
- Warrick B, Hill M, Lehr B, Mowry J, Gummin D, Anderson D, Wahl M, Goetz R, Smolinske S. A review of bath salt exposures reported to six regional poison centers. Clin Toxicol (Phila) 2011; 49:567.
- Winstock AR, Marsden J, Mitcheson L. What should be done about mephedrone? BMJ 2010; 340:c1605.
- Centers for Disease Control and Prevention. Emergency department visits after use of a drug sold as “bath salts” – Michigan, November 13, 2010–March 31, 2011. MMWR Morb Mortal Wkly Rep 2011; 60:624–627.
- Schifano F, Albanese A, Fergus S, Stair JL, Deluca P, Corazza O, Davey Z, Corkery J, Siemann H, Scherbaum N, Farre’ M, Torrens M, Demetrovics Z, Ghodse AH; Psychonaut Web Mapping; ReDNet Research Groups. Mephedrone (4-methylmethcathinone; ‘meow meow’): Chemical, pharmacological and clinical issues. Psychopharmacology (Berl) 2011; 214:593–602.
- Dulaney AR. Characteristics of “bath salts” exposures reported to a regional poison center. Clin Toxicol (Phila) 2011; 49:529–530.
- Wood DM, Greene SL, Dargan PI. Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone. Emerg Med J 2011; 28:280–282.
- Hagerkvist R, Hulten P, Personne M. Increasing abuse of new cathinone derivatives in Sweden – A poisons centre study for the years 2008–2009. Clin Toxicol (Phila) 2010; 48:291–292.
- Valento M, Feinzimer B, Bryant SM. Drowning in bath salts: A case of abuse with fatal outcome. Clin Toxicol (Phila) 2011; 49:528–529.
- Yost P. ‘Bath salts’ drugs temporarily banned as hazardous. Msnbc.com. September 8, 2011. Available at http://www.msnbc.msn.com/id/44438843/ns/health-health_care/. Last accessed on September 8, 2011.
- US Drug Enforcement Administration. Schedules of controlled substances: Temporary placement of three synthetic cathinones into schedule 1. Federal Register 2011; 76:65371–65375.
- Wood DM, Greene SL, Dargan PI. Control of mephedrone (4-methylmethcathinone) in the UK appears effective in reducing presentations to the emergency department with acute toxicity related to its use. Clin Toxicol (Phila) 2011; 49:522–523.
- Wood DM, Litauszki G, Davies S, Ramsey J, Dargan PI. Impact of classification of piperazines and cathinones in the UK. Clin Toxicol (Phila) 2011; 49:217–218.